Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy

Схожие документы

• Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
  по: Colleoni, Marco, et al.
  Опубликовано: (2010)
• Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
  по: Viale, G., et al.
  Опубликовано: (2010)
• A Risk Score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer
  по: Dellapasqua, Silvia, et al.
  Опубликовано: (2012)
• Second non-breast primary cancer following adjuvant therapy for early breast cancer: A report from the International Breast Cancer Study Group
  по: Gianni, Lorenzo, et al.
  Опубликовано: (2008)
• Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
  по: Viale, Giuseppe, et al.
  Опубликовано: (2008)